Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study")

This study has been completed.
Janssen Services, LLC
Information provided by (Responsible Party):
Philip Grant, Stanford University Identifier:
First received: November 4, 2013
Last updated: October 13, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)